UNSPSC 51101677: Sodium stibogluconate

This classification denotes an enzyme inhibitor and antiparasitic agent with the molecular formula C12H18O17Sb2.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V083S0159D, chemically known as trinatrium bis(gluconato(3)-o2,o3,o4)hydroxooxido-oxy-bis-antimonat(v) but generally known as sodium stibogluconate, which bears US NIH Compound Identifier 16683012. European Medicines Agency schedules Sodium stibogluconate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04492MIG.

UNSPSC 51101677 Sodium stibogluconate is a Commodity code that in recent state and local procurement activity covers a broader range of pharmaceutical and medical products than its nominal title suggests. The recent opportunities tagged to this code reflect solicitations for naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, and medical and first aid supplies for emergency response — indicating that state and local governments are using this code to procure pharmaceutical products, emergency medical supplies, and related health-sector goods. Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas Health and Human Services Commission), municipal fire departments (City of Tampa), and cooperative purchasing alliances serving multiple states (Minnesota Multistate Cooperative Purchasing Alliance). The activity spans health departments, fire rescue divisions, and state pharmacy benefit programs, signaling demand across diverse public-sector health and emergency-response functions.

Recent activity concentrates in Florida, Texas, and Minnesota. Seminole County, Florida released an IFB on June 30, 2026 (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building and contract potential of up to three years including renewals. The City of Tampa issued an IFB (due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a sheltered-market designation for certified Small Local Business Enterprises offering a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance released an RFP (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local facilities including Oregon, with two-year contract terms and awards to be effective July 1, 2026. The Texas Health and Human Services Commission issued an RFI (due April 3, 2026) to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling exploratory procurement ahead of a formal RFP.